Pharmaceuticals, Biotechnology and Life Sciences
Company to host conference call on April 7 at 8 a.m. ETBOSTON, April 06, 2025 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…
HONOLULU, Hawaii, April 05, 2025 (GLOBE NEWSWIRE) — Arialief is nutritional support specifically designed to offer sciatic nerve relief. It…
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,…
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS,…
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company)…
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…
MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical…
— Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 — — Signed Multiple Development Agreements with New and Existing…
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 03, 2025 (GLOBE NEWSWIRE) — VAXIL BIO…
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10…